Filters: Author is Bhatia, Shailender [Clear All Filters]
Immunobiology of merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.. Current oncology reports. 13(6):488-97.. 2011.
Systemic therapy of metastatic melanoma: on the road to cure.. Oncology (Williston Park, N.Y.). 29(2):126-35.. 2015.
PD-1 Blockade in Melanoma: A Promising Start, but a Long Way to Go.. JAMA. 315(15):1573-5.. 2016.
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study.. Journal for immunotherapy of cancer. 2:2.. 2014.
Systemic therapy for metastatic melanoma in 2012: dawn of a new era.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(3):403-12.. 2012.
Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96.. 2009.
Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.. Journal of the American Academy of Dermatology. 70(3):449-55.. 2014.
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.. The New England journal of medicine. 366(26):2455-65.. 2012.
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.. Cancer immunology research. 2(1):27-36.. 2014.
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.. Proceedings of the National Academy of Sciences of the United States of America. 109(12):4592-7.. 2012.
Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100).. Journal of translational medicine. 13:2068.. 2015.
Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma.. Current treatment options in oncology. 14(2):249-63.. 2013.
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.. The New England journal of medicine.. 2016.
A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2015.
Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma-Specific Survival Independent of Stage.. The Journal of investigative dermatology.. 2012.
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.. Cancer immunology research. 2(11):1071-9.. 2014.
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors.. Investigational new drugs.. 2016.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Journals List
- Ovid (guest or library account)
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog (Account Login)
- Document Delivery Form
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Authored Papers (Intranet)